DNA

ANEW MEDICAL, INC. Acquires License to Needle-Free Dry Powder Autoinjector from Transfertech Sherbrooke (“TTS”)

NEW YORK, Aug. 21, 2024 (GLOBE NEWSWIRE) -- ANEW MEDICAL, INC. (“ANEW” or the “Company”) (Nasdaq: WENA) announced the signing…

1 year ago

ANY LAB TEST NOW AND ARCPOINT CREATE LARGEST FRANCHISE DIRECT ACCESS LAB TESTING GROUP IN THE UNITED STATES

Greenville, South Carolina, Aug. 20, 2024 (GLOBE NEWSWIRE) -- ARCpoint Inc. (TSXV: ARC) (the “Company” or “ARCpoint”) is pleased to…

1 year ago

StaffDNA® Announced as Title Sponsor for the Cure Bowl in Orlando

PLANO, Texas, Aug. 20, 2024 /PRNewswire/ -- StaffDNA®, creator of the Digital Marketplace for Healthcare Careers®, is thrilled to announce its…

1 year ago

Walmart Launches Jukebox: Natural Women’s Personal Care Line Hits Stores Nationwide

From the team behind Dr. Squatch, Jukebox offers handcrafted soaps and deodorants that mix nostalgic yet innovative scents, with natural…

1 year ago

Telomir Pharmaceuticals Featured in Local ABC Exclusive Showing Positive Outcomes of Proposed Age Reversal Pill in Dogs

Promising results with Telomir-1 Demonstrates Potential in Promoting Life Quality and Longevity in Senior DogsTAMPA, FL / ACCESSWIRE / August…

1 year ago

Roche responds to WHO’s declaration of a global health emergency due to the ongoing mpox outbreak

Roche is committed to supporting all those working to overcome the mpox outbreak by providing access to high-quality Polymerase Chain…

1 year ago

AIM ImmunoTech Announces Print Publication and Further Positive Findings from a Study Evaluating Ampligen® in the Treatment of Pancreatic Cancer in the Journal Clinical Cancer Research

Data demonstrate compelling evidence of the immune-stimulatory properties linked to TLR-3 activation through Ampligen Additional commentary published discussing the potential…

1 year ago

LAVA Reports Second Quarter 2024 Financial Results and Business Update

Continued progress in Phase 1/2a dose escalation for LAVA-1207, including the monotherapy arm, now enrolling in dose level 12, and…

1 year ago

Tonix Pharmaceuticals Announces First Patient Enrolled in Phase 2 CATALYST Study of TNX-1300 for the Treatment of Cocaine Intoxication

CATALYST is a Phase 2 single-blind, placebo-controlled, proof-of-concept study in patients presenting to the emergency department More than 27,569 individuals…

1 year ago

Applied DNA To Submit Application to New York State Department of Health to Expand Intended Use of Linea Mpox Virus 1.0 Assay to Mpox Clade I

STONY BROOK, NY / ACCESSWIRE / August 19, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA), a leader in…

1 year ago